CD14 Antibodies

Santa Cruz Biotechnology features a diverse variety of CD14 Antibodies to support research in immunology and cell biology. CD14 Antibodies demonstrate effectiveness in various applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CD14 is a glycoprotein that plays a crucial role in the immune response by acting as a co-receptor for the detection of bacterial lipopolysaccharides (LPS). CD14 is primarily expressed on the surface of monocytes and macrophages, facilitating the recognition and clearance of pathogens. The study of CD14 is essential for understanding innate immunity and the inflammatory response. CD14 monoclonal antibodies enable researchers to explore cellular signaling pathways and immune system regulation. CD14 monoclonal antibodies support investigations into inflammatory diseases and immune disorders. Santa Cruz Biotechnology monoclonal antibodies for CD14 continue to advance scientific understanding of immune system functions, contributing to breakthrough discoveries in immunology research.